Cargando…
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials
OBJECTIVE: Data from two double-blind, randomized, Phase III studies were analysed to investigate the ability of Routine Assessment of Patient Index Data 3, DAS28 (CRP), modified (M)-DAS28 (CRP) and Simplified or Clinical Disease Activity Indices to predict structural damage progression in RA. METHO...
Autores principales: | Keystone, Edward C, Ahmad, Harris A, Yazici, Yusuf, Bergman, Martin J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382603/ https://www.ncbi.nlm.nih.gov/pubmed/31819995 http://dx.doi.org/10.1093/rheumatology/kez455 |
Ejemplares similares
-
Reductions in disease activity in the AMPLE trial: clinical response by baseline disease duration
por: Schiff, Michael, et al.
Publicado: (2016) -
Ample subvarieties of algebraic varieties
por: Hartshorne, Robin
Publicado: (1970) -
Colorectal endometriosis: ample data without definitive recommendations
por: Moawad, GN, et al.
Publicado: (2021) -
AMPL: A Data-Driven Modeling Pipeline for Drug Discovery
por: Minnich, Amanda J., et al.
Publicado: (2020) -
COVID-19 in Children: An Ample Review
por: Ciuca, Ioana M
Publicado: (2020)